Trial Profile
Phase I Study of CT-2106 in Patients With Advanced Malignancy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2013
Price :
$35
*
At a glance
- Drugs CT 2106 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 17 Jun 2013 New trial record